|
home
|

eating disorders
Eating is controlled by many factors, including appetite,
food availability, family, peer, and cultural practices, and
attempts at voluntary control. Dieting to a body weight
leaner than needed for health is highly promoted by current
fashion trends, sales campaigns for special foods, and in some
activities and professions. Eating disorders involve serious
disturbances in eating behavior, such as extreme and unhealthy
reduction of food intake or severe overeating, as well as feelings of
distress or extreme concern about body shape or weight.
Researchers are investigating how and why initially voluntary behaviors,
such as eating smaller or larger amounts of food than usual, at some point
move beyond control in some people and develop into an eating disorder.
Studies on the basic biology of appetite control and its alteration by
prolonged overeating or starvation have uncovered enormous complexity, but
in the long run have the potential to lead to new pharmacologic treatments
for eating disorders.
Eating disorders are not due to a failure of will or behavior; rather, they
are real, treatable medical illnesses in which certain maladaptive patterns
of eating take on a life of their own. The main types of eating disorders
are anorexia nervosa and bulimia nervosa. A third type, binge-eating
disorder, has been suggested but has not yet been approved as a formal
psychiatric diagnosis. Eating disorders frequently develop during
adolescence or early adulthood, but some reports indicate their onset can
occur during childhood or later in adulthood.
Eating disorders frequently co-occur with other psychiatric disorders such
as depression, substance abuse, and anxiety disorders.1 In addition, people
who suffer from eating disorders can experience a wide range of physical
health complications, including serious heart conditions and kidney failure
which may lead to death. Recognition of eating disorders as real and
treatable diseases, therefore, is critically important.
Females are much more likely than males to develop an eating disorder. Only
an estimated 5 to 15 percent of people with anorexia or bulimia and an
estimated 35 percent of those with binge-eating disorder are male.
People with eating disorders often do not recognize or admit that they are
ill. As a result, they may strongly resist getting and staying in treatment.
Family members or other trusted individuals can be helpful in ensuring that
the person with an eating disorder receives needed care and rehabilitation.
For some people, treatment may be long term.
Research Findings and Directions
Research is contributing to advances in the understanding and treatment of
eating disorders.
NIMH-funded scientists and others continue to investigate the effectiveness
of psychosocial interventions, medications, and the combination of these
treatments with the goal of improving outcomes for people with eating
disorders.
Research on interrupting the binge-eating cycle has shown that once a
structured pattern of eating is established, the person experiences less
hunger, less deprivation, and a reduction in negative feelings about food
and eating. The two factors that increase the likelihood of bingeing—hunger
and negative feelings—are reduced, which decreases the frequency of binges.
Several family and twin studies are suggestive of a high heritability of
anorexia and bulimia, and researchers are searching for genes that confer
susceptibility to these disorders. Scientists suspect that multiple genes
may interact with environmental and other factors to increase the risk of
developing these illnesses. Identification of susceptibility genes will
permit the development of improved treatments for eating disorders.
Other studies are investigating the neurobiology of emotional and social
behavior relevant to eating disorders and the neuroscience of feeding
behavior.
Scientists have learned that both appetite and energy expenditure are
regulated by a highly complex network of nerve cells and molecular
messengers called neuropeptides. These and future discoveries will provide
potential targets for the development of new pharmacologic treatments for
eating disorders.
Further insight is likely to come from studying the role of gonadal
steroids. Their relevance to eating disorders is suggested by the clear
gender effect in the risk for these disorders, their emergence at puberty or
soon after, and the increased risk for eating disorders among girls with
early onset of menstruation.
This publication was written by Melissa Spearing, Office of Communications
and Public Liaison, National Institute of Mental Health (NIMH). Expert
assistance was provided by NIMH Director Steven E. Hyman, M.D., and NIMH
staff members Bruce N. Cuthbert, Ph.D., Regina Dolan-Sewell, Ph.D.,
Benedetto Vitiello, Ph.D., Clarissa K. Wittenberg, and Constance Burr.
Editorial assistance was provided by Margaret Strock and Lisa D. Alberts,
also NIMH staff members.
All material in this publication is in the public domain and may be copied
or reproduced without permission of the Institute. Citation of the source is
appreciated.
NIH Publication No. 01-4901
Printed 2001
disclaimer
copyright
|

Tell a friend |

Printer version |

Link to us |

Newsletter |

Articles |

Back to top |
|